-
Je něco špatně v tomto záznamu ?
Can gut microbes play a role in mental disorders and their treatment
K. Latalova, M. Hajda, J. Prasko,
Jazyk angličtina Země Chorvatsko
Typ dokumentu časopisecké články
PubMed
28291971
DOI
10.24869/psyd.2017.28
Knihovny.cz E-zdroje
- MeSH
- depresivní poruchy farmakoterapie mikrobiologie patofyziologie MeSH
- duševní poruchy farmakoterapie mikrobiologie patofyziologie MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- mozek účinky léků patofyziologie MeSH
- neurovývojové poruchy farmakoterapie mikrobiologie patofyziologie MeSH
- obsedantně kompulzivní porucha farmakoterapie mikrobiologie patofyziologie MeSH
- probiotika terapeutické užití MeSH
- střevní mikroflóra účinky léků fyziologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The gut microbes, collectively called microbiota, are linked to the brain through a bidirectional system that involves the vagus nerve, the immune system, and various neurotransmitters. Stress response, memory functions, social behavior, and mood are modulated by microbiota. Furthermore, microbiota play a role in the development of the central nervous system. These features, established largely in rodent studies, have informed hypotheses about the role of microbiota in human psychiatric disorders. Microbiota affect phenomena that are known to be parts of the depression phenotype, such as exaggerated response to stress and inflammatory features. Furthermore, the role of microbiota in neurodevelopment and in the modulation of social behavior suggests the possibility of its role in autism spectrum disorder and in schizophrenia. If altered, microbiota play a role in psychiatric disorders, then efforts to normalize the gut microbial population by the ingestion of probiotics (live bacteria) could have antidepresssant or antipsychotic effects. Testing such hypotheses in translational human studies is a matter of future research.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17030964
- 003
- CZ-PrNML
- 005
- 20171103102233.0
- 007
- ta
- 008
- 171025s2017 ci f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.24869/psyd.2017.28 $2 doi
- 035 __
- $a (PubMed)28291971
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ci
- 100 1_
- $a Latalova, Klara $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Department of Psychiatry, Olomouc University Hospital, I. P. Pavlova 6, Olomouc 77500, Czech Republic, klaralat@centrum.cz.
- 245 10
- $a Can gut microbes play a role in mental disorders and their treatment / $c K. Latalova, M. Hajda, J. Prasko,
- 520 9_
- $a The gut microbes, collectively called microbiota, are linked to the brain through a bidirectional system that involves the vagus nerve, the immune system, and various neurotransmitters. Stress response, memory functions, social behavior, and mood are modulated by microbiota. Furthermore, microbiota play a role in the development of the central nervous system. These features, established largely in rodent studies, have informed hypotheses about the role of microbiota in human psychiatric disorders. Microbiota affect phenomena that are known to be parts of the depression phenotype, such as exaggerated response to stress and inflammatory features. Furthermore, the role of microbiota in neurodevelopment and in the modulation of social behavior suggests the possibility of its role in autism spectrum disorder and in schizophrenia. If altered, microbiota play a role in psychiatric disorders, then efforts to normalize the gut microbial population by the ingestion of probiotics (live bacteria) could have antidepresssant or antipsychotic effects. Testing such hypotheses in translational human studies is a matter of future research.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a mozek $x účinky léků $x patofyziologie $7 D001921
- 650 _2
- $a depresivní poruchy $x farmakoterapie $x mikrobiologie $x patofyziologie $7 D003866
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a střevní mikroflóra $x účinky léků $x fyziologie $7 D000069196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a duševní poruchy $x farmakoterapie $x mikrobiologie $x patofyziologie $7 D001523
- 650 _2
- $a neurovývojové poruchy $x farmakoterapie $x mikrobiologie $x patofyziologie $7 D065886
- 650 _2
- $a obsedantně kompulzivní porucha $x farmakoterapie $x mikrobiologie $x patofyziologie $7 D009771
- 650 _2
- $a probiotika $x terapeutické užití $7 D019936
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hajda, Miroslav
- 700 1_
- $a Prasko, Jan
- 773 0_
- $w MED00006897 $t Psychiatria Danubina $x 0353-5053 $g Roč. 29, č. 1 (2017), s. 28-30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28291971 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171103102328 $b ABA008
- 999 __
- $a ok $b bmc $g 1254557 $s 991991
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 29 $c 1 $d 28-30 $i 0353-5053 $m Psychiatria Danubina $n Psychiatr Danub $x MED00006897
- LZP __
- $a Pubmed-20171025